Morgan Stanley Remains a Buy on Welltower (WELL)
In a report released today, Ronald Kamdem from Morgan Stanley maintained a Buy rating on Welltower, with a price target of $215.00.
President's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Kamdem is a 5-star analyst with an average return of 10.3% and a 62.35% success rate. Kamdem covers the Real Estate sector, focusing on stocks such as Alexandria Equities, Welltower, and Regency Centers.
In addition to Morgan Stanley, Welltower also received a Buy from Citi’s Nicholas Joseph in a report issued today. However, on February 13, TipRanks – Anthropic downgraded Welltower (NYSE: WELL) to a Hold.
Based on Welltower’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $3.25 billion and a net profit of $96.44 million. In comparison, last year the company earned a revenue of $2.22 billion and had a net profit of $119.97 million
Read More on WELL:
Disclaimer & DisclosureReport an Issue
- Welltower price target raised to $245 from $215 at Citi
- Regulatory Risks Loom Over Welltower: How Policy Shifts Could Hit Healthcare REIT Valuations and Deals
- Welltower price target raised to $240 from $228 at UBS
- Welltower price target raised to $230 from $204 at Cantor Fitzgerald
- Welltower Earnings Call Highlights Powerful SHOP Momentum
